Pfizer, Inc. (PFE) Financials

PFE Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2024 219.5 billion 126.9 billion
June 30, 2024 216.2 billion 128.2 billion
March 31, 2024 221.1 billion 128.5 billion
Dec. 31, 2023 226.5 billion 137.2 billion

PFE Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 6.1 billion 274.0 million
June 30, 2024 -2.4 billion 206.0 million
March 31, 2024 387.0 million 220.0 million
Dec. 31, 2023 4.2 billion 121.0 million

PFE Net Income
Graph available only for supporters. Become a supporter to see it.
DateNet Income
Sept. 30, 2024 4.5 billion
June 30, 2024 24.0 million
March 31, 2024 3.1 billion
Dec. 31, 2023 -3.3 billion

PFE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 10.0 billion 58.0 billion -
June 30, 2024 7.1 billion 57.5 billion -2.6 billion
March 31, 2024 11.9 billion 61.3 billion -
Dec. 31, 2023 12.7 billion 61.5 billion -2.8 billion

PFE Shares Outstanding
Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
Sept. 30, 2024 5.7 billion
June 30, 2024 5.7 billion
March 31, 2024 5.7 billion
Dec. 31, 2023 5.6 billion

PFE Expenses
Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 651.0 million 2.6 billion 3.2 billion -
June 30, 2024 637.0 million 2.7 billion 3.7 billion -
March 31, 2024 704.0 million 2.5 billion 3.5 billion -
Dec. 31, 2023 1.0 billion 2.8 billion 4.5 billion 3.7 billion

PFE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 17.7 billion 6.6 billion
June 30, 2024 13.3 billion 5.0 billion
March 31, 2024 14.9 billion 4.4 billion
Dec. 31, 2023 14.2 billion 8.6 billion

PFE Revenue by Segment
Graph available only for supporters. Become a supporter to see it.

PFE

List: Contenders

Price: $25.72

52 week price:
24.48
31.54

5-year range yield:
3.13%
6.61%

Forward Dividend Yield: 6.72%

Payout Ratio: -365.22%

Payout Ratio Range:
-1005.23%
12122.22%

Dividend Per Share: 1.72 USD

Earnings Per Share: 1.41 USD

P/E Ratio: 18.26

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 23.8 million

Ebitda: 3.6 billion

Market Capitalization: 145.9 billion

Average Dividend Frequency: 4

Years Paying Dividends: 54

DGR3: 2.55%

DGR5: -0.54%

DGR10: 9.76%

DGR20: 9.72%

Links: